Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vangelis G Manolopoulos

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Clinical Chemistry and Laboratory Medicine|July 10, 2007
Pharmacogenomics and adverse drug reactions in diagnostic and clinical practiceVangelis G Manolopoulos
Pharmacology|October 23, 2004
Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytesAnna Tavridou, Vangelis G Manolopoulos
Pharmacogenomics|October 26, 2022
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?Georgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|November 27, 2020
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entryGeorgia Ragia, Vangelis G Manolopoulos
Expert Opinion on Therapeutic Patents|May 22, 2009
Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369Anna Tavridou, Vangelis G Manolopoulos
European Journal of Pharmacology|November 24, 2004
Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivoAnna Tavridou, Vangelis G Manolopoulos
European Journal of Clinical Pharmacology|July 23, 2020
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapiesGeorgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|March 28, 2018
From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?Georgia Ragia, Vangelis G Manolopoulos
Current Pharmaceutical Biotechnology|February 28, 2017
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and BeyondGeorgia Ragia, Vangelis G Manolopoulos
Current Drug Metabolism|March 20, 2024
Fluoropyrimidine Toxicity: the Hidden Secrets of DPYDVangelis G Manolopoulos, Georgia Ragia
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Clinical Chemistry and Laboratory Medicine|July 10, 2007
Pharmacogenomics and adverse drug reactions in diagnostic and clinical practiceVangelis G Manolopoulos
Pharmacology|October 23, 2004
Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytesAnna Tavridou, Vangelis G Manolopoulos
Pharmacogenomics|October 26, 2022
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?Georgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|November 27, 2020
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entryGeorgia Ragia, Vangelis G Manolopoulos
Expert Opinion on Therapeutic Patents|May 22, 2009
Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369Anna Tavridou, Vangelis G Manolopoulos
European Journal of Pharmacology|November 24, 2004
Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivoAnna Tavridou, Vangelis G Manolopoulos
European Journal of Clinical Pharmacology|July 23, 2020
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapiesGeorgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|March 28, 2018
From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?Georgia Ragia, Vangelis G Manolopoulos
Current Pharmaceutical Biotechnology|February 28, 2017
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and BeyondGeorgia Ragia, Vangelis G Manolopoulos
Current Drug Metabolism|March 20, 2024
Fluoropyrimidine Toxicity: the Hidden Secrets of DPYDVangelis G Manolopoulos, Georgia Ragia
Pageof 12